Miranda L. Broz

4.0k citations

16 papers · 2.1k indexed · 2 hit papers · h-index 10

Co-authors: Matthew F. Krummel Mikhail Binnewies Denise M. Wolf Amanda E. Nelson Mark B. Headley Dusan Bogunovic Tsuneyasu Kaisho Edward W. Roberts
Topics: Immunotherapy and Immune Responses (9 papers)Cancer Immunotherapy and Biomarkers (8 papers)Immune cells in cancer (6 papers)
Cited by: Immunology Oncology Molecular Biology
Journals: Journal of Clinical Investigation Journal of Clinical Oncology The Journal of Immunology
Partner nations: United States Germany France

In The Last Decade

Miranda L. Broz

14 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity

2014 889 citations Miranda L. Broz, Mikhail Binnewies et al. Cancer Cell profile →
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma

2016 729 citations Edward W. Roberts, Miranda L. Broz et al. Cancer Cell profile →

Peers

Countries citing papers authored by Miranda L. Broz

Since Specialization

Citations

This map shows the geographic impact of Miranda L. Broz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda L. Broz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda L. Broz more than expected).

Fields of papers citing papers by Miranda L. Broz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda L. Broz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda L. Broz. The network helps show where Miranda L. Broz may publish in the future.

Co-authorship network of co-authors of Miranda L. Broz

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda L. Broz. A scholar is included among the top collaborators of Miranda L. Broz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda L. Broz. Miranda L. Broz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Design and Characterization of an Anti-Clec9a Antibody Armed with CpG Oligonucleotides To Enable Targeted Delivery of Adjuvant to Cross-Presenting Dendritic Cells 2025 ·ACS Chemical Biology ·Sayumi Yamazoe,(unknown),Qian Zhang,Arvind Rajpal,Tim W. Sproul,Pavel Strop,Miranda L. Broz	0
2	Targeted Delivery of TLR7 Agonists to the Tumor Microenvironment Enhances Tumor Immunity via Activation of Tumor-Resident Myeloid Cells 2025 ·Bioconjugate Chemistry ·Emanuela Sega,Srikanth Kotapati,Yam B. Poudel,Qinqin Cheng,(unknown),(unknown),(unknown),Chetana Rao,Sanjeev Gangwar,Tim W. Sproul,(unknown),Miranda L. Broz,Pavel Strop,Sayumi Yamazoe	4
3	Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses 2022 ·Drug Metabolism and Disposition ·Zheng Yang,Surendran Rajendran,(unknown),(unknown),Murali Gururajan,Zheng Lin,(unknown),Stanley R. Krystek,James Loy,Yuan Cheng,Stephen M. Carl,(unknown),Yun Wang,John T. Mehl,(unknown),(unknown),Miranda L. Broz,Lois D. Lehman‐McKeeman,Paul E. Morin,Robert F. Graziano	2
4	A multi‐omic single cell sequencing approach to develop a CD8 T cell specific gene signature for anti‐PD1 response in solid tumors 2022 ·International Journal of Cancer ·Namit Kumar,Simon Papillon‐Cavanagh,Hao Tang,Shiliang Wang,(unknown),(unknown),(unknown),Steven G. Grinnell,Miranda L. Broz,Daniel J. Tenney,Michael Wichroski,Alice M. Walsh,Yanhua Hu,Joseph L. Benci	5
5	Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy 2020 ·The Journal of Immunology ·Tiffany C. Blair,Shelly Bambina,Alejandro Alice,Gwen Kramer,Terry R. Medler,Jason R. Baird,Miranda L. Broz,Garth W. Tormoen,Victoria Troesch,Marka R. Crittenden,Michael J. Gough	48
6	STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis 2016 ·Cancer Research ·Laura Jones,Miranda L. Broz,(unknown),(unknown),Ryuhjin Ahn,Dongmei Zuo,Josie Ursini‐Siegel,Michael Hallett,Matthew F. Krummel,William J. Muller	84
7	Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanomabreakdown → 2016 ·Cancer Cell ·Edward W. Roberts,Miranda L. Broz,Mikhail Binnewies,Mark B. Headley,Amanda E. Nelson,Denise M. Wolf,Tsuneyasu Kaisho,Dusan Bogunovic,Nina Bhardwaj,Matthew F. Krummel	729
8	Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment 2016 ·Journal of Clinical Investigation ·(unknown),Jordan Ye,Miranda L. Broz,Kevin C. Barry,Juliet Goldsmith,Timothy Marsh,(unknown),Matthew F. Krummel,Jayanta Debnath	62
9	The Emerging Understanding of Myeloid Cells as Partners and Targets in Tumor Rejection 2015 ·Cancer Immunology Research ·Miranda L. Broz,Matthew F. Krummel	50
10	Deep profiling of tumor immune microenvironment (TME) with fluorescence activated cell sorting (FACS) in advanced melanoma. 2015 ·Journal of Clinical Oncology ·Kimberly Loo,Katy K. Tsai,Michael D. Rosenblum,Neharika Khurana,Jimmy J. Hwang,(unknown),Miranda L. Broz,Matthew F. Krummel,Paul C. Tumeh,Alain P. Algazi,Adil Daud	1
11	Abstract B65: Dissecting the tumor myeloid compartment reveals rare activating antigen presenting cells, critical for T cell immunity 2015 ·Cancer Immunology Research ·Miranda L. Broz,Mikhail Binnewies,Bijan Boldajipour,Amanda E. Nelson,(unknown),David J. Erle,Andrea J. Barczak,Michael D. Rosenblum,Adil Daud,Diane L. Barber,Sebastián Amigorena,Laura van ‘t Veer,Anne I. Sperling,Denise M. Wolf,Matthew F. Krummel	0
12	Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity 2014 ·Cancer Cell ·Miranda L. Broz,Mikhail Binnewies,Bijan Boldajipour,Amanda E. Nelson,Joshua L. Pollack,David J. Erle,Andrea J. Barczak,Michael Rosenblum,Adil Daud,Diane L. Barber,Sebastián Amigorena,Laura J. van’t Veer,Anne I. Sperling,Denise M. Wolf,Matthew F. Krummel	114
13	Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunitybreakdown → 2014 ·Cancer Cell ·Miranda L. Broz,Mikhail Binnewies,Bijan Boldajipour,Amanda E. Nelson,Joshua L. Pollack,David J. Erle,Andrea J. Barczak,Michael D. Rosenblum,Adil Daud,Diane L. Barber,Sebastián Amigorena,Laura J. van’t Veer,Anne I. Sperling,Denise M. Wolf,Matthew F. Krummel	889
14	Arabidopsis Tetraspanins Are Confined to Discrete Expression Domains and Cell Types in Reproductive Tissues and Form Homo- and Heterodimers When Expressed in Yeast 2013 ·PLANT PHYSIOLOGY ·Leonor C. Boavida,Peng Qin,Miranda L. Broz,Jörg D. Becker,Susan P. McCormick	67
15	In-Depth Investigation of Archival and Prospectively Collected Samples Reveals No Evidence for XMRV Infection in Prostate Cancer 2012 ·PLoS ONE ·Deanna Lee,Jaydip Das Gupta,Christina Gaughan,Imke Steffen,Ning Tang,(unknown),Xiaoxing Qiu,Anatoly Urisman,Nicole Fischer,Ross J. Molinaro,Miranda L. Broz,Gerald Schochetman,Eric A. Klein,Don Ganem,Joseph L. DeRisi,Graham Simmons,John Hackett,Robert H. Silverman,Charles Y. Chiu	30
16	Extended use of cranial CT in the evaluation of patients with stroke and transient ischaemic attacks 1991 ·Neuroradiology ·J. Stevens,(unknown),R. W. Kerslake,Miranda L. Broz,S. Barter	19

About Miranda L. Broz

Miranda L. Broz is a scholar working on Immunology, Oncology and Physiology, having authored 16 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Immunology (1.6k citations), Oncology (1.3k citations) and Molecular Biology (517 citations). Miranda L. Broz has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Matthew F. Krummel, Mikhail Binnewies, Denise M. Wolf, Amanda E. Nelson, Mark B. Headley, Dusan Bogunovic, Tsuneyasu Kaisho, Edward W. Roberts, Nina Bhardwaj and David J. Erle. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact